This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignees: The University of Texas System, Pfizer Corporation. Active years: 2011-2015.
Location History:
- Antwerpen, BE (2011)
- Antwerp, BE (2012 - 2015)
Company Filing History:
Years Active: 2011-2015
Title: Pedro Lory: Innovator in Biochemical Research
Introduction
Pedro Lory is a notable inventor based in Antwerp, Belgium. He has made significant contributions to the field of biochemical research, particularly in the development of peptide sequences and receptor modulators. With a total of 3 patents to his name, Lory's work has implications for both medical treatment and bacterial detection.
Latest Patents
Lory's latest patents include "Substrate peptide sequences for plague plasminogen activator and uses thereof." This invention focuses on peptide sequences identified from combinatorial libraries that serve as substrates for plague plasminogen activator (Pla). The patent also discusses peptides derived from these substrates, which can be chemically modified to inactivate the proteolytic activity of Pla. Additionally, it highlights the use of these substrates in detecting bacteria that express the omptin family of proteases. Another significant patent is "Modulators of CCR9 receptor and methods of use thereof." This patent provides compounds that modulate CCR9 receptor activity, along with methods for treating diseases associated with this modulation.
Career Highlights
Throughout his career, Pedro Lory has worked with prestigious organizations, including the University of Texas System and Pfizer Corporation. His experience in these institutions has allowed him to collaborate on groundbreaking research and innovations in the field of biochemistry.
Collaborations
Lory has collaborated with notable colleagues such as Vladimir L Motin and Sadhana Chauhan. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Pedro Lory is a distinguished inventor whose work in peptide sequences and receptor modulators has the potential to impact medical science significantly. His contributions to the field are marked by his innovative patents and collaborations with esteemed professionals.